357 related articles for article (PubMed ID: 8916829)
41. The role of nitric oxide in the cerebrovascular response to hypercapnia.
Smith JJ; Lee JG; Hudetz AG; Hillard CJ; Bosnjak ZJ; Kampine JP
Anesth Analg; 1997 Feb; 84(2):363-9. PubMed ID: 9024030
[TBL] [Abstract][Full Text] [Related]
42. Evidence from its cardiovascular effects that 7-nitroindazole may inhibit endothelial nitric oxide synthase in vivo.
Zagvazdin Y; Sancesario G; Wang YX; Share L; Fitzgerald ME; Reiner A
Eur J Pharmacol; 1996 May; 303(1-2):61-9. PubMed ID: 8804912
[TBL] [Abstract][Full Text] [Related]
43. Possible involvement of neuronal nitric oxide synthase enzyme in early-phase isoflurane-induced hypotension in rats.
Ellenberger EA; Lucas HL; Mueller JL; Barrington PL; Chung E; Ohgami Y; Quock RM
Life Sci; 2004 Dec; 76(5):499-507. PubMed ID: 15556163
[TBL] [Abstract][Full Text] [Related]
44. Nitric oxide synthesis inhibition modifies the cardiotoxicity of tetracaine and lidocaine.
Heavner JE; Shi B; Pitkänen M
Anesth Analg; 1999 Apr; 88(4):717-22. PubMed ID: 10195510
[TBL] [Abstract][Full Text] [Related]
45. Intestinal motor depression by 7-nitroindazole through an action unrelated to nitric oxide synthase inhibition.
Heinemann A; Holzer P
Pharmacology; 1999 Dec; 59(6):310-20. PubMed ID: 10575325
[TBL] [Abstract][Full Text] [Related]
46. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
47. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects.
Moore PK; Wallace P; Gaffen Z; Hart SL; Babbedge RC
Br J Pharmacol; 1993 Sep; 110(1):219-24. PubMed ID: 7693278
[TBL] [Abstract][Full Text] [Related]
48. The effect of chronic nitric oxide synthase inhibition on blood pressure and heart rate in unrestrained pregnant rats as recorded by radiotelemetry.
Buhimschi CS; Gokdeniz R; Saade GR; Buhimschi IA; Garfield RE
Am J Obstet Gynecol; 1999 Jul; 181(1):159-64. PubMed ID: 10411813
[TBL] [Abstract][Full Text] [Related]
49. Modification of bupivacaine toxicity by nonselective versus neuronal nitric oxide synthesis inhibition.
Shi B; Heavner JE
Anesth Analg; 1997 Apr; 84(4):804-9. PubMed ID: 9085962
[TBL] [Abstract][Full Text] [Related]
50. Cerebellar nitric oxide is increased during isoflurane anesthesia compared to halothane anesthesia: a microdialysis study in rats.
Loeb AL; Raj NR; Longnecker DE
Anesthesiology; 1998 Sep; 89(3):723-30. PubMed ID: 9743411
[TBL] [Abstract][Full Text] [Related]
51. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
52. Chronic treatment with nitric oxide synthase (NOS) inhibitor profoundly reduces cerebellar NOS activity and cyclic guanosine monophosphate but does not modify minimum alveolar anesthetic concentration.
Adachi T; Shinomura T; Nakao S; Kurata J; Murakawa M; Shichino T; Seo N; Mori K
Anesth Analg; 1995 Oct; 81(4):862-5. PubMed ID: 7574024
[TBL] [Abstract][Full Text] [Related]
53. Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies.
Buhimschi IA; Shi SQ; Saade GR; Garfield RE
Am J Obstet Gynecol; 2001 Mar; 184(4):686-93. PubMed ID: 11262473
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of nitric oxide synthase decreases anesthetic requirements of intravenous anesthetics in Xenopus laevis.
Tonner PH; Scholz J; Lamberz L; Schlamp N; Schulte am Esch J
Anesthesiology; 1997 Dec; 87(6):1479-85. PubMed ID: 9416733
[TBL] [Abstract][Full Text] [Related]
55. Lack of correlation between the reduction of sevoflurane MAC and the cerebellar cyclic GMP concentrations in mice treated with 7-nitroindazole.
Ichinose F; Mi WD; Miyazaki M; Onouchi T; Goto T; Morita S
Anesthesiology; 1998 Jul; 89(1):143-8. PubMed ID: 9667304
[TBL] [Abstract][Full Text] [Related]
56. Nitric oxide synthase inhibitors do not substitute in rats trained to discriminate phencyclidine from saline.
Wiley JL; Harvey SA; Balster RL
Eur J Pharmacol; 1999 Feb; 367(1):7-11. PubMed ID: 10082258
[TBL] [Abstract][Full Text] [Related]
57. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
Gaballa MA; Raya TE; Hoover CA; Goldman S
Cardiovasc Res; 1999 Jun; 42(3):627-35. PubMed ID: 10533602
[TBL] [Abstract][Full Text] [Related]
58. Cerebral blood flow in primates is increased by isoflurane over time and is decreased by nitric oxide synthase inhibition.
McPherson RW; Kirsch JR; Tobin JR; Ghaly RF; Traystman RJ
Anesthesiology; 1994 Jun; 80(6):1320-7. PubMed ID: 7516627
[TBL] [Abstract][Full Text] [Related]
59. Endothelial nitric oxide synthase activity involves in the protective effect of ascorbic acid against penicillin-induced epileptiform activity.
Yildirim M; Ayyildiz M; Agar E
Seizure; 2010 Mar; 19(2):102-8. PubMed ID: 20089420
[TBL] [Abstract][Full Text] [Related]
60. Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors.
Mésenge C; Verrecchia C; Allix M; Boulu RR; Plotkine M
J Neurotrauma; 1996 Jan; 13(1):11-6. PubMed ID: 8714858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
